BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157 Peptide and Lyme Disease: Tissue Repair and Immune Support In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking Important Update on FDA Changes Concerning Peptides BPC 157 Benefits For Woman: Reasons To Try The BPC 157 Peptide